Innovative Technology Vitestro's autonomous blood drawing systems, including the Aletta device, represent cutting-edge automation and AI integration in medical diagnostics, offering hospitals a new way to improve accuracy and efficiency in blood collection.
Proven Market Adoption Recent collaborations with Northwestern Medical Group and several product launches demonstrate strong market validation, highlighting opportunities to target healthcare providers seeking to modernize their phlebotomy processes with autonomous solutions.
Growth and Funding With a recent funding round of $21 million and revenues estimated between one and ten million dollars, Vitestro is positioned for expansion, presenting potential sales opportunities in expanding hospital networks and diagnostics centers across Europe and North America.
Regulatory and Industry Track Record Vitestro’s ongoing development and deployment of fully automated blood collection systems align with industry trends toward minimally invasive, tech-driven healthcare solutions, making it attractive for health systems focused on innovation and patient safety.
Global Expansion Potential Leadership appointments in North America and a growing portfolio of collaborations suggest strategic plans for international market entry, providing sales prospects with hospitals and clinics seeking autonomous phlebotomy technology globally.
$250M$500M
$500M$1B
$500M$1B
$100M$250M
$500M$1B
$25M$50M
$100M$250M
$500M$1B
$250M$500M
$1B$10B
$100M$250M
$1M$10MVitestro uses 8 technology products and services including Docker, git, Linux, and more. Explore Vitestro's tech stack below.
| Vitestro Email Formats | Percentage |
| First.Last@vitestro.com | 72% |
| First.Middle.Last@vitestro.com | 21% |
| First@vitestro.com | 6% |
| Last_First@vitestro.com | 1% |
Medical Equipment ManufacturingNetherlands51-200 Employees
Vitestro will be the first to bring autonomous blood drawing technology to European hospitals. Blood drawing, performed billions of times per year worldwide, is key to clinical diagnosis. Given a growing population and shortages of healthcare personnel, there is a clear need for a future-proof system to keep up with demand for diagnostics.
Company Overview
Funding & FinancialsVitestro has raised a total of $21M of funding over 4 rounds. Their latest funding round was raised on Apr 30, 2024 in the amount of $21M.
Vitestro's revenue is estimated to be in the range of $1M$10M
Funding & FinancialsVitestro has raised a total of $21M of funding over 4 rounds. Their latest funding round was raised on Apr 30, 2024 in the amount of $21M.
Vitestro's revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com